HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $498,953,038 | +36.3% | 4,312,845 | +21.2% | 1.02% | +26.3% |
| Q2 2023 | $366,114,631 | +60.6% | 3,559,695 | +70.4% | 0.80% | +41.0% |
| Q1 2023 | $227,994,115 | -59.3% | 2,089,006 | -57.6% | 0.57% | -62.8% |
| Q4 2022 | $560,762,928 | +666.9% | 4,927,618 | +317.1% | 1.54% | +582.7% |
| Q3 2022 | $73,125,000 | +113.1% | 1,181,531 | +222.5% | 0.22% | +38.9% |
| Q2 2021 | $34,307,000 | +461.4% | 366,372 | +451.8% | 0.16% | +440.0% |
| Q1 2021 | $6,111,000 | -56.0% | 66,393 | -62.8% | 0.03% | -70.6% |
| Q3 2020 | $13,876,000 | +349.1% | 178,635 | +221.3% | 0.10% | +277.8% |
| Q2 2020 | $3,090,000 | -77.7% | 55,593 | -88.1% | 0.03% | -83.5% |
| Q1 2020 | $13,840,000 | -60.0% | 467,249 | -51.1% | 0.16% | -20.4% |
| Q4 2019 | $34,581,000 | +354.5% | 955,277 | +241.9% | 0.21% | +296.2% |
| Q3 2019 | $7,609,000 | -69.8% | 279,437 | -73.4% | 0.05% | -67.7% |
| Q2 2019 | $25,205,000 | – | 1,049,997 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |